• 1
    Treanor JJ. Influenza virus. In MandellGL, BennettJE, DolinR, eds. Principles and Practice of Infectious Diseases, 6th Ed. New York : Churchill Livingstone Inc., 2004: 20602085.
  • 2
    Vilchez RA, Fung J, Kusne S. The pathogenesis and management of influenza virus infection in organ transplant recipients. Transpl Infect Dis 2002; 4: 177182.
  • 3
    Nicholson KG. Human influenza. In: NicholsonKG, WebsterRG, HayAJ, eds. Textbook of Influenza. Oxford , England : Blackwell Science, 1998: 219264.
  • 4
    Ison MG, Hayden FG. Viral infections in immunocompromised patients: What's new with respiratory viruses? Curr Opin Infect Dis 2002; 15: 355367.
  • 5
    Vilchez RA, McCurry K, Dauber J et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2: 287291.
  • 6
    Ljungman P, Andersson J, Aschan J et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244247.
  • 7
    Vilchez RA, Dauber J, Kusne S. Infectious etiology of bronchiolitis obliterans: The respiratory viruses connection—Myth or reality? Am J Transplant 2003; 3: 245249.
  • 8
    Kumar D, Erdman D, Keshavjee S et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 2005; 5: 20312036.
  • 9
    Russell CJ, Webster RG. The genesis of a pandemic influenza virus. Cell 2005; 123: 368371.
  • 10
    Belshe RB. The origins of pandemic influenza—Lessons from the 1918 virus. N Engl J Med 2005; 353: 22092211.
  • 11
    Horimoto T, Kawaoka Y. Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 2005; 3: 591600.
  • 12
    Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, Fanning TG. Characterization of the 1918 influenza virus polymerase genes. Nature 2005; 437: 889893.
  • 13
    Tumpey TM, Basler CF, Aguilar PV et al. Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 2005; 310: 7780.
  • 14
    Kaye D, Pringle CR. Avian influenza viruses and their implication for human health. Clin Infect Dis 2005; 40: 108112.
  • 15
    Monto AS. The threat of an avian influenza pandemic. N Engl J Med 2005; 352: 323325.
  • 16
    Yuen KY, Chan PK, Peiris M et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998; 351: 467471.
  • 17
    The Writing Committee of the World Health Organization (WHO) Consultation on Human Influenza A/H5. Avian influenza A (H5N1) infection in humans. N Engl J Med 2005; 353: 13741385.
  • 18
    Li KS, Guan Y, Wang J et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2004; 430: 209213.
  • 19
    Liu J, Xiao H, Lei F et al. Highly pathogenic H5N1 influenza virus infection in migratory birds. Science 2005; 309: 12061206.
  • 20
    Ungchusak K, Auewarakul P, Dowell SF et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005; 352: 333340.
  • 21
    Tran TH, Nguyen TL, Nguyen TD et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med 2004; 350: 11791188.
  • 22
    Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W et al. Human disease from influenza A (H5N1), Thailand, 2004. Emerg Infect Dis 2005; 11: 201209.
  • 23
    Cheung CY, Poon LL, Lau AS et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet 2002; 360: 18311837.
  • 24
    Thorson A, Petzold M, Nguyen TK, Ekdahl K. Is exposure to sick or dead poultry associated with flulike illness?: A population-based study from a rural area in Vietnam with outbreaks of highly pathogenic avian influenza. Arch Intern Med 2006; 166: 119123.
  • 25
    Horimoto T, Fukuda N, Iwatsuki-Horimoto K et al. Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003. J Vet Med Sci 2004; 66: 303305.
  • 26
    Kuiken T, Rimmelzwaan G, Van Riel D et al. Avian H5N1 influenza in cats. Science 2004; 306: 241241.
  • 27
    Kumar D, Humar A. Emerging viral infections in transplant recipients. Curr Opin Infect Dis 2005; 18: 337341.
  • 28
    Hayden FG, Treanor JJ, Fritz RS et al. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment. JAMA 1999; 282: 12401246.
  • 29
    Nichols WG, Guthrie KA, Corey L, Boeckh M. Influenza infections after hematopoietic stem cell transplantation: Risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 2004; 39: 13001306.
  • 30
    Kumar D, Tellier R, Draker R, Levy G, Humar A. Severe Acute Respiratory Syndrome (SARS) in a liver transplant recipient and guidelines for donor SARS screening. Am J Transplant 2003; 3: 977981.
  • 31
    De Jong MD, Bach VC, Phan TQ et al. Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N Engl J Med 2005; 352: 686691.
  • 32
    Rimmelzwaan GF, Van Riel D, Baars M et al. Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol 2006; 168: 176183.
  • 33
    Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004; 4 (Suppl 10): 160163.
  • 34
    Blumberg EA, Albano C, Pruett T et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22: 295302.
  • 35
    Duchini A, Hendry RM, Nyberg LM, Viernes ME, Pockros PJ. Immune response to influenza vaccine in adult liver transplant recipients. Liver Transpl 2001; 7: 311313.
  • 36
    Lawal A, Basler C, Branch A, Gutierrez J, Schwartz M, Schiano TD. Influenza vaccination in orthotopic liver transplant recipients: Absence of post administration ALT elevation. Am J Transplant 2004; 4: 18051809.
  • 37
    Mazzone PJ, Mossad SB, Mawhorter SD, Mehta AC, Schilz RJ, Maurer JR. The humoral immune response to influenza vaccination in lung transplant patients. Eur Respir J 2001; 18: 971976.
  • 38
    Soesman NM, Rimmelzwaan GF, Nieuwkoop NJ et al. Efficacy of influenza vaccination in adult liver transplant recipients. J Med Virol 2000; 61: 8593.
  • 39
    Glezen WP. Cold-adapted, live attenuated influenza vaccine. Expert Rev Vaccines 2004; 3: 131139.
  • 40
    Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: Current recommendations and protocols. Clin Microbiol Rev 2003; 16: 357364.
  • 41
    Stephenson I, Nicholson KG, Wood JM, Zambon MC, Katz JM. Confronting the avian influenza threat: Vaccine development for a potential pandemic. Lancet Infect Dis 2004; 4: 499509.
  • 42
    Webby RJ, Perez DR, Coleman JS et al. Responsiveness to a pandemic alert: Use of reverse genetics for rapid development of influenza vaccines. Lancet 2004; 363: 10991103.
  • 43
    Ilyushina NA, Govorkova EA, Webster RG. Detection of amantadine-resistant variants among avian influenza viruses isolated in North America and Asia. Virology 2005; 341: 102106.
  • 44
    Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005; 353: 13631373.
  • 45
    Machado CM, Boas LS, Mendes AV et al. Oseltamivir to control influenza complications after bone marrow transplantation. Bone Marrow Transplant 2004; 34: 111114.
  • 46
    De Jong MD, Tran TT, Truong HK et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 2005; 353: 26672672.